"Immunoblotting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.
Descriptor ID |
D015151
|
MeSH Number(s) |
E05.478.566.320 E05.601.470.320
|
Concept/Terms |
Immunoblotting, Reverse- Immunoblotting, Reverse
- Immunoblottings, Reverse
- Reverse Immunoblottings
- Reverse Immunoblotting
Immunoelectroblotting- Immunoelectroblotting
- Immunoelectroblottings
- Electroimmunoblotting
- Electroimmunoblottings
Dot Immunoblotting- Dot Immunoblotting
- Immunoblotting, Dot
- Dot Immunoblottings
- Immunoblottings, Dot
|
Below are MeSH descriptors whose meaning is more general than "Immunoblotting".
Below are MeSH descriptors whose meaning is more specific than "Immunoblotting".
This graph shows the total number of publications written about "Immunoblotting" by people in this website by year, and whether "Immunoblotting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 3 | 3 |
1996 | 0 | 2 | 2 |
1997 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 8 | 8 |
2000 | 0 | 6 | 6 |
2001 | 0 | 5 | 5 |
2002 | 0 | 8 | 8 |
2003 | 0 | 10 | 10 |
2004 | 0 | 16 | 16 |
2005 | 0 | 15 | 15 |
2006 | 0 | 8 | 8 |
2007 | 0 | 9 | 9 |
2008 | 0 | 9 | 9 |
2009 | 0 | 12 | 12 |
2010 | 0 | 10 | 10 |
2011 | 0 | 14 | 14 |
2012 | 0 | 8 | 8 |
2013 | 0 | 12 | 12 |
2014 | 0 | 10 | 10 |
2015 | 0 | 12 | 12 |
2016 | 0 | 9 | 9 |
2017 | 0 | 2 | 2 |
2018 | 0 | 4 | 4 |
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoblotting" by people in Profiles.
-
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nat Commun. 2021 12 06; 12(1):7041.
-
The exploration of N6-deoxyadenosine methylation in mammalian genomes. Protein Cell. 2021 10; 12(10):756-768.
-
EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal Inflammation. Shock. 2020 09; 54(3):394-401.
-
Quantification of ERK Kinase Activity in Biological Samples Using Differential Sensing. ACS Chem Biol. 2020 01 17; 15(1):83-92.
-
Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli. PLoS Negl Trop Dis. 2019 11; 13(11):e0007825.
-
Non-Cell Autonomous Roles for CASK in Optic Nerve Hypoplasia. Invest Ophthalmol Vis Sci. 2019 08 01; 60(10):3584-3594.
-
Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle. Nat Commun. 2018 11 30; 9(1):5104.
-
Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1. Diabetes. 2019 02; 68(2):291-304.
-
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II. Nat Commun. 2018 10 22; 9(1):4394.
-
Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours. Vet Comp Oncol. 2018 Dec; 16(4):630-635.